TREA

97701222 - ALPHATAC

Follow

Information

  • Trademark
  • 97701222
  • Serial Number
    97701222
  • Filing Date
    December 02, 2022
    2 years ago
  • Transaction Date
    May 23, 2025
    2 months ago
  • Status Date
    May 06, 2025
    3 months ago
  • Published for Opposition Date
    March 11, 2025
    4 months ago
  • Location Date
    May 06, 2025
    3 months ago
  • Status Code
    688
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    CORWIN, KEVIN
  • Attorney Docket Number
    HDCPA-T466US
    Attorney Name
    Clifford D. Hyra
    Law Office Assigned Location Code
    M30
  • Owners
Information
Mark Drawing Code
4
Mark Identification
ALPHATAC
Case File Statements
  • GS0051: Pharmaceutical preparations and substances, namely, biotherapeutics for targeted protein degradation in cancer, immunological disease, and autoimmunological disease; Medical preparations and substances, namely, liquid, solid, and lyophilized protein-based preparations for medical uses and treatments for cancer, immunological disease, and autoimmunological disease; Medical and veterinary preparations and substances in the nature of liquid, solid, and lyophilized protein-based biotherapeutic preparations for the treatment, mitigation, diagnosis, or prevention of diseases, conditions, and symptoms related to metabolism, allergies, immune and inflammatory diseases, infectious diseases, the cardiovascular system, the pulmonary system, the respiratory system, oncology, dermatology, the gastrointestinal system, topical illnesses, neurology, endocrinology, the urological system, the reproductive system, nutritional needs, ophthalmic system, renal system, blood and blood-related disorders, integumentary and lymphatic systems in humans and animals; Veterinary preparations in the nature of medication for use in the treatment, mitigation, diagnosis, or prevention of diseases, conditions, and symptoms related to metabolism, allergies, immune and inflammatory diseases, infectious diseases, the cardiovascular system, the pulmonary system, the respiratory system, oncology, dermatology, the gastrointestinal system, topical illnesses, neurology, endocrinology, the urological system, the reproductive system, nutritional needs, ophthalmic system, renal system, blood and blood-related disorders, integumentary and lymphatic systems in humans and animals; therapeutic preparations for pharmaceutical, medical and veterinary purposes, namely, pharmaceutical preparations for the treatment of disease, namely, cancer, immunological disorders, and autoimmunological disorders in humans and animals; bioculture preparations for pharmaceutical, medical, and veterinary purposes, namely, cultures of microorganisms for medical or veterinary use; Preparations and substances for use in drug discovery, namely, clinical medical reagents; all of the aforesaid goods excluding means for pest control, fungicides, germicides and herbicides and excluding means for diagnostics
  • GS0421: Science and technology services, namely, scientific and technological research in the field of pharmaceuticals, medical science, and veterinary science; Natural science services, namely, scientific research; Scientific research, namely, medical, bacteriological, chemical, bio-technical and pharmacological research services; Clinical research, namely, scientific research in the nature of conducting clinical trials for others; medical laboratory services; conducting early evaluations in the field of new pharmaceuticals; Consultancy relating to pharmaceutical research and development; Drug discovery services; all of the aforesaid services not relating to means for pest control, fungicides, germicides and herbicide, and not relating to means for diagnostics
Case File Event Statements
  • 12/6/2022 - 2 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 12/28/2022 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 9/12/2023 - a year ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 9/23/2023 - a year ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 9/23/2023 - a year ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 9/23/2023 - a year ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 12/21/2023 - a year ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 12/21/2023 - a year ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 12/21/2023 - a year ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 5/31/2024 - a year ago
    11 - FINAL REFUSAL E-MAILED Type: GNFR
  • 5/31/2024 - a year ago
    10 - FINAL REFUSAL WRITTEN Type: CNFR
  • 5/31/2024 - a year ago
    12 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 8/30/2024 - 11 months ago
    15 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 8/30/2024 - 11 months ago
    16 - APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Type: XELR
  • 8/30/2024 - 11 months ago
    14 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 8/30/2024 - 11 months ago
    17 - APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Type: XELG
  • 8/30/2024 - 11 months ago
    13 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR
  • 12/13/2024 - 7 months ago
    18 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 12/19/2024 - 7 months ago
    19 - ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED Type: ERRR
  • 3/5/2025 - 5 months ago
    20 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 3/11/2025 - 4 months ago
    21 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 5/6/2025 - 3 months ago
    23 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 3/11/2025 - 4 months ago
    22 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 5/22/2025 - 2 months ago
    24 - TEAS POST PUBLICATION AMENDMENT RECEIVED Type: EPPA